EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Leading developments in basic research on aspergillosis and mucormycosis

Argha Sarkar, Drauzio E N Rangel, Nir Osherov

Fungal Biology · 2025

DOI: 10.1016/j.funbio.2025.101574 ↗

Kurz gefasst

Editorial in der Zeitschrift Fungal Biology, 2025. Verfasst von Argha Sarkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel Aviv University, Israel. Hauptthemen laut MEDLINE: Mucormycosis, Aspergillosis, Biomedical Research. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Israel Science Foundation, Coordination of Higher Education Personnel Improvement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial presents an overview of notable contributions in basic research on aspergillosis and mucormycosis published between 2022 and 2024. Basic research in aspergillosis saw major advances in the field of genomics brought about by inexpensive whole-genome sequencing of hundreds of isolates. This has deepened our understanding of Aspergillus fumigatus population structure, gene diversity, and the evolution of azole antifungal resistance. Basic research in mucormycosis saw interesting developments in our understanding of the interactions between Rhizopus microsporus and endosymbiotic bacteria that protect it against predatory soil amoeba and increase its virulence in models of infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisAspergillosisBiomedical ResearchHumansAspergillus fumigatusRhizopusAntifungal AgentsVirulenceDrug Resistance, Fungal

Stichwörter der Autor:innen

Aspergillus fumigatusEndosymbiontGenomicsRhizopus oryzae

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel Aviv University, Israel.
  • Inbioter - Institute of Biotechnology Rangel, Caixa Postal 5, Itatiba, SP, 13250-970, Brazil.
  • Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel Aviv University, Israel. Electronic address: nosherov@tauex.tau.ac.il.

Förderung

  • National Council for Scientific and Technological Development
  • Israel Science Foundation
  • Coordination of Higher Education Personnel Improvement

Zitieren

APA

Sarkar, A., Rangel, D. E. N., & Osherov, N. (2025). Leading developments in basic research on aspergillosis and mucormycosis. Fungal Biology. https://doi.org/10.1016/j.funbio.2025.101574

Vancouver

Sarkar A, Rangel DEN, Osherov N. Leading developments in basic research on aspergillosis and mucormycosis. Fungal Biology. 2025. doi:10.1016/j.funbio.2025.101574

BibTeX
@article{Sarkar2025,
  author = {Sarkar, Argha and Rangel, Drauzio E N and Osherov, Nir},
  title = {Leading developments in basic research on aspergillosis and mucormycosis},
  journal = {Fungal Biology},
  year = {2025},
  doi = {10.1016/j.funbio.2025.101574}
}
Kostenlos starten →